Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, 44121 Ferrara, Italy.
Center 'Chiara Gemmo and Elio Zago' for the Research on Thalassemia, University of Ferrara, 44121 Ferrara, Italy.
Genes (Basel). 2023 Feb 23;14(3):556. doi: 10.3390/genes14030556.
One of the most relevant pathophysiological hallmarks of β-thalassemia is the accumulation of toxic α-globin chains inside erythroid cells, which is responsible for their premature death (hemolysis). In this context, the availability of an experimental model system mimicking the excess in α-globin chain production is still lacking. The objective of the present study was to produce and characterize K562 cellular clones forced to produce high amounts of α-globin, in order to develop an experimental model system suitable for studies aimed at the reduction of the accumulation of toxic α-globin aggregates. In the present study, we produced and characterized K562 cellular clones that, unlike the original K562 cell line, stably produced high levels of α-globin protein. As expected, the obtained clones had a tendency to undergo apoptosis that was proportional to the accumulation of α-globin, confirming the pivotal role of α-globin accumulation in damaging erythroid cells. Interestingly, the obtained clones seemed to trigger autophagy spontaneously, probably to overcome the accumulation/toxicity of the α-globin. We propose this new model system for the screening of pharmacological agents able to activate the full program of autophagy to reduce α-globin accumulation, but the model may be also suitable for new therapeutical approaches targeted at the reduction of the expression of the α-globin gene.
β-地中海贫血症最重要的病理生理学特征之一是过多的毒性α-珠蛋白链在红细胞内堆积,导致红细胞过早死亡(溶血)。在这种情况下,仍然缺乏模拟α-珠蛋白链过度产生的实验模型系统。本研究的目的是产生和表征能够大量产生α-珠蛋白的 K562 细胞克隆,以开发一种适合旨在减少毒性α-珠蛋白聚集积累的研究的实验模型系统。在本研究中,我们产生和表征了 K562 细胞克隆,与原始 K562 细胞系不同,这些克隆能够稳定地产生高水平的α-珠蛋白蛋白。正如预期的那样,获得的克隆具有凋亡的趋势,这与α-珠蛋白的积累成正比,证实了α-珠蛋白积累在破坏红细胞中的关键作用。有趣的是,获得的克隆似乎自发触发自噬,可能是为了克服α-珠蛋白的积累和毒性。我们提出这个新的模型系统用于筛选能够激活自噬的药理学药物,以减少α-珠蛋白的积累,但该模型也可能适用于针对降低α-珠蛋白基因表达的新治疗方法。